article thumbnail

Medicare Advantage enrollment has exploded since 2006. But policy hasn't kept up, researchers warn

Fierce Healthcare

Medicare Advantage enrollment has exploded since 2006. But policy hasn't kept up, researchers warn fdiamond Thu, 02/09/2023 - 15:41

81
article thumbnail

From neurosurgery to focused ultrasound: Not if, but when

pharmaphorum

In today’s podcast, web editor Nicole Raleigh speaks with Dr Neal Kassell, chair and founder of the Focused Ultrasound Foundation and previously a neurosurgeon, who created the Foundation in 2006 to improve the lives of millions of people with serious medical disorders by accelerating the development and adoption of focused ultrasound.

105
105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

OSF HealthCare President Sister Diane Marie McGrew dies at 57

Fierce Healthcare

McGrew had served as president of the 16-hospital Franciscan health system since 2006, and also held longstanding roles on its various boards. Sister Diane Marie McGrew, president of the OSF HealthCare, died on Sunday. No plans for her succession have been disclosed.

Hospitals 115
article thumbnail

STAT+: Drug may make chemotherapies less effective in cancer patients with obesity — but many doctors are in the dark

STAT

At issue is a medicine called posaconazole that was approved in 2006 in the U.S. The information, however, is not in the label because the drug — originally manufactured by Merck — was never fully tested in this population. And the company has refused to update the language. but is now also sold by generic companies.

article thumbnail

E-Cigarette Use Among Patients with CVD Rebounds After Initial Decline

Drug Topics

E-cigarettes have garnered popularity since entering the market in 2006 as a potential aid for smoking cessation, but their use has been associated with increased adverse cardiovascular events.

98
article thumbnail

STAT+: Buoyed by billion-dollar deals, its stock is up 50% this year. How did Boston Scientific get its mojo back?

STAT

This might be surprising considering the damage caused by its bet-the-farm, $27 billion deal in 2006 for pacemaker company Guidant, which sealed a victory  in its bidding war  against the larger Johnson & Johnson.

101
101
article thumbnail

How to Run DMC? It’s Tricky – FDA’s New Draft Guidance Provides Updated Recommendations on How to Best Use Data Monitoring Committees in Clinical Trials

The FDA Law Blog

Clissold — The trio of CDER, CBER, and CDRH released a new draft guidance titled “ Use of Data Monitoring Committees in Clinical Trials ” that revises the 2006 guidance “Establishment and Operation of Clinical Trial Data Monitoring Committees” and, when final, will replace the 2006 guidance.